INTRODUCTION
============

Toll-like receptors (TLRs) allow the innate immune system to distinctively identify foreign pathogenic molecules, but, if overstimulated, can become mediators of sepsis. Lipopolysaccharide (LPS) is known to play a critical role in sepsis. However, as our understanding of Gram-negative and Gram-positive infections expands, other TLRs ligands, including lipoteichoic acid (LTA), peptidoglycan (PepG), lipoproteins, flagellin, and CpG-rich unmethylated bacterial DNA (bactDNA), have been recognized to be involved \[[@B1]\]. PepG, a main component of bacterial cell walls, can activate leukocytes, generate proinflammatory cytokines such as tumor necrosis factor alpha (TNF-*α*), interleukin-1 (IL-1), IL-6, and cause systemic inflammatory response syndrome \[[@B2], [@B3], [@B4]\]. PepG was also shown to mediate platelet aggregation in *Staphylococcus aureus* septicemia \[[@B5]\], induce tissue factor (TF) in monocytes, and display procoagulant activity \[[@B6]\]. BactDNA induces the production of TNF-*α* in macrophages in vitro. BactDNA leads to septic shock and death in sensitive mice \[[@B7]\]. Because of the cooperation between TLRs and the common denominators downstream of TLR activation, synergistic effects between microbial pathogenic compounds have been observed. Whereas LTA can cause only moderate hypotension, PepG coadministered with LTA induces multiorgan dysfunction and death in rats \[[@B8], [@B9]\]. BactDNA also increases the toxicity of LPS in mice \[[@B10]\]. However, synergistic effects between bactDNA and PepG have not been reported. Moreover, although IL-1, induced by bacterial toxins including bactDNA, has been shown to induce TF in endothelial cells \[[@B11], [@B12]\], the effect of bactDNA on the regulation of TF in monocytes has not been described.

The goal of this study was to investigate the effect of bactDNA and PepG, on the induction of a marker of inflammation, TNF-*α*, in human peripheral blood mononuclear cells (PBMC), and of a coagulation marker, TF, in monocytes, and to test the hypothesis that bactDNA and PepG can exert synergistic effects.

MATERIALS AND METHODS
=====================

Peripheral blood mononuclear cells were prepared by Ficoll separation of peripheral blood from healthy volunteers as previously described \[[@B13]\]. Mononuclear cells were plated at a density of 10^6^ cells/mL in 1.5 mL RPMI 1640 (Irvine Scientific, Santa Ana, Calif), supplemented with 100 U/mL penicillin/streptomicin, 2 mM glutamine, and 3% fetal calf serum, and treated with PepG (Sigma, St Louis, Mich), bactDNA (KM Biomedicals, Aurora, Ohio; LPS \< 0.2 EU/mL measured by the limulus amebocyte lysate assay \[[@B13]\]), or both. TNF-*α* was measured by ELISA from the culture supernatant after 5-hour incubation and elimination of nonadherent cells. The TNF-*α* ELISA kit from Cell Sciences (Norwood, Mass) was used. The coefficient of variation for the TNF-*α* ELISA was less than 8.9% for duplicate measurements of a single culture. The lowest detection limit was 10 pg/mL.

Tissue factor in monocytes was evaluated from the corresponding PBMC cultures used for TNF-*α* analysis. After 5 hours of treatment, TF was extracted from the adherent cells with phosphate buffered saline containing 0.1% Triton X100 as recommended by the manufacturer for subsequent TF ELISA. The Imubind kit from American Diagnostica (Greenwich, Conn) was used. The coefficient of variation for the TF ELISA was less than 9.7% for duplicate measurements of a single culture. The sensitivity of the assay was 10 pg/mL.

Numerical data were analyzed by using the Student *t* test. A *P* value less than .05 was considered statistically significant.

RESULTS
=======

Induction of TNF-*α* secretion in PBMC cultures was used as an in vitro assay for the determination of an inflammatory reaction. TF is an initiator of coagulation and was used as an indicator of a procoagulant reaction. There was no detectable TNF-*α* or TF in untreated cells, and no significant difference in the amount of proteins extracted from monocytes between treatment conditions was measured (not shown). Both PepG and bactDNA applied individually to PBMC were able to induce TNF-*α* and TF in a dose-response fashion ([Figure 1](#F1){ref-type="fig"}). In presence of high concentration of PepG (3 *μ*g/mL), adding bactDNA did not generate significantly more TNF-*α* or TF, except at 15 *μ*g/mL bactDNA for TNF-*α*. However, when lower concentrations of PepG (1 *μ*g/mL or 0.3 *μ*g/mL) were used, treatment with bactDNA and PepG simultaneously generated more TNF-*α* and TF than when adding the effect of the two compounds used separately (*P* \< .05) ([Figure 1](#F1){ref-type="fig"}). The induction of TNF-*α* and TF was up to 15- and 10-fold higher, respectively, when PepG and bactDNA were present in conjunction, than when adding the effect of the two molecules alone. These results indicate that PepG and bactDNA act in synergy, even when bactDNA alone does not induce detectable TNF-*α* or TF by itself.

DISCUSSION
==========

The present results demonstrate the concomitant induction of TNF-*α* and TF by PepG and bactDNA in PBMC, and a synergistic effect between the two molecules. Although the molecular mechanism for this synergy remains to be elucidated, it could involve direct effects on common downstream signaling pathways, or indirect effects mediated by secreted compounds following PepG or bactDNA action.

The increase in TF expression on monocytes by bactDNA is a new finding and may have significance in disseminated intravascular coagulation. Indeed, an increase in TF elicited by PepG and/or bactDNA could have local as well as systemic effects, as TF has been shown to be present on circulating monocytes \[[@B14]\]. TNF-*α* is an important early mediator of host responses to pyrogens and is the only endogenous mediator capable of triggering the entire spectrum of metabolic, hemodynamic, tissue, and cytokine cascade responses of septic shock. These results are also significant in as much as the crosstalk between inflammation and coagulation is an aspect to consider in the quest of an effective therapy for septic shock. The synergistic effects of bactDNA and PepG also have implications for the pathogenesis of sepsis, where each molecule, although present at low concentrations in vivo, is likely to amplify the effect of another one, as hypothesized previously \[[@B15]\].
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